Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Abdulmajed

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Die Pharmazie|November 2, 2005
Topical delivery of retinyl ascorbate co-drug: 6. Determination of toxic dose and antioxidant activity in cultured human epidermal keratinocytesK Abdulmajed, C McGuigan, C M Heard
Skin Pharmacology and Physiology|June 17, 2006
Topical delivery of retinyl ascorbate co-drug. 5. In vitro degradation studiesK Abdulmajed, C McGuigan, C M Heard
Skin Pharmacology and Physiology|November 6, 2004
Topical delivery of retinyl ascorbate co-drug. 2. Comparative skin tissue and keratin binding studiesK Abdulmajed, C M Heard, C McGuigan, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Die Pharmazie|November 2, 2005
Topical delivery of retinyl ascorbate co-drug: 6. Determination of toxic dose and antioxidant activity in cultured human epidermal keratinocytesK Abdulmajed, C McGuigan, C M Heard
Skin Pharmacology and Physiology|June 17, 2006
Topical delivery of retinyl ascorbate co-drug. 5. In vitro degradation studiesK Abdulmajed, C McGuigan, C M Heard
Skin Pharmacology and Physiology|November 6, 2004
Topical delivery of retinyl ascorbate co-drug. 2. Comparative skin tissue and keratin binding studiesK Abdulmajed, C M Heard, C McGuigan, et al.
Pageof 1